FDA Adverse Event Injury Summary report: N

GEL-ONE X-LINKED HYALUR 3ML

MDR report key: 12159692 · Received July 13, 2021

Report

Report Number
0001822565-2021-01923
Event Type
Injury
Date Received
July 13, 2021
Date of Event
May 25, 2021
Report Date
July 21, 2021
Manufacturer
SEIKAGAKU CORPORATION
Product Code
MOZ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION.

Description of Event or Problem · 0

IT WAS REPORTED THAT PATIENT UNDERWENT GEL ONE INJECTION APPROXIMATELY TWO (2) MONTHS AGO. PATIENT EXPERIENCED PAIN AFTER INJECTION AND DOCTOR GAVE HER A CORTISONE SHOT RIGHT AFTER TO ALLEVIATE THE PAIN. CORTISONE SHOT DID NOT HELP AND PATIENT HAS BEEN EXPERIENCING PAIN EVER SINCE. PATIENT CALLED APPROXIMATELY THREE (3) WEEKS AGO TO REPORT THAT HER PAIN HAD GOTTEN WORSE WITHIN THE PAST 48 HOURS. ATTEMPTS HAVE BEEN MADE AND NO FURTHER INFORMATION HAS BEEN PROVIDED.

Additional Manufacturer Narrative · 1

(B)(4). PRODUCT DEVICE CODE - MOZ. CUSTOMER HAS INDICATED THAT THE PRODUCT WILL NOT BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION, AS IT REMAINS IMPLANTED. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT UNDERWENT A GEL-ONE INJECTION APPROXIMATELY SEVEN (7) WEEKS AGO. SUBSEQUENTLY, PATIENT HAS NOT EXPERIENCED RELIEF SINCE THE PROCEDURE, AND REPORTED AN INCREASE OF PAIN APPROXIMATELY FIVE (5) WEEKS POST-INJECTION. ATTEMPTS HAVE BEEN MADE AND NO FURTHER INFORMATION HAS BEEN PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1053089 GEL-ONE X-LINKED HYALUR 3ML PROSTHESIS, BIOLOGICS MOZ SEIKAGAKU CORPORATION NI UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 Other